Basic Information
| LncRNA/CircRNA Name | RERT |
| Synonyms | NA |
| Region | NA |
| Ensemble | NA |
| Refseq | NA |
Classification Information
| Regulatory Mechanism | Biological Function | Clinical Application | |||
|---|---|---|---|---|---|
| TF | Immune | Survival | |||
| Enhancer | Apoptosis | Drug | |||
| Variant | Cell Growth | Circulating | |||
| MiRNA | EMT | Metastasis | |||
| Methylation | Coding Ability | Recurrence |
Cancer&Entry Information
| Cancer Name | lung cancer |
| ICD-0-3 | C34 |
| Methods | qPCR |
| Sample | lung cancer tissues |
| Expression Pattern | up-regulated |
| Function Description | The expressions of RERT-lncRNA and EGLN2 in tumor tissues were higher than adjacent normal tissues, Kaplan-Meier survival analysis found that the patients with the Ins/Ins genotype of rs10680577 in RERT-lncRNA had a longer OS than those patients carried with the Ins/Del+ Del/Del genotype. |
| Pubmed ID | 30073577 |
| Year | 2018 |
| Title | Correlations of an Insertion/Deletion Polymorphism (rs10680577) in the RERT-lncRNA With the Susceptibility, Clinicopathological Features, and Prognosis of Lung Cancer. |
External Links
| Links for RERT | GenBank HGNC NONCODE |
| Links for lung cancer | OMIM COSMIC |